Advertisement

Topics

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias,Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 9, Status: Authorised

05:50 EDT 13 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias,Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 9, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias,Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 9, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Repatha, evolocumab, Dyslipidemias,Hypercholesterolemia, Date of authorisation: 17/07/2015, Revision: 9, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement